BioCardia Total Debt vs. Number Of Shares Shorted

Based on the key profitability measurements obtained from BioCardia's financial statements, BioCardia may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess BioCardia's ability to earn profits and add value for shareholders.
For BioCardia profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioCardia to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioCardia utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioCardia's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioCardia over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Please note, there is a significant difference between BioCardia's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioCardia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioCardia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BioCardia Number Of Shares Shorted vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining BioCardia's current stock value. Our valuation model uses many indicators to compare BioCardia value to that of its competitors to determine the firm's financial worth.
BioCardia is rated second in total debt category among its peers. It is number one stock in number of shares shorted category among its peers . The ratio of Total Debt to Number Of Shares Shorted for BioCardia is about  308.90 . Comparative valuation analysis is a catch-all technique that is used if you cannot value BioCardia by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

BioCardia Total Debt vs. Competition

BioCardia is rated second in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 6.64 Million. BioCardia retains roughly 1.31 Million in total debt claiming about 20% of equities under Health Care industry.
Total debt  Capitalization  Valuation  Revenue  Workforce

BioCardia Number Of Shares Shorted vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

BioCardia

Total Debt

 = 

Bonds

+

Notes

 = 
1.31 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

BioCardia

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
4.26 K
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

BioCardia Number Of Shares Shorted Comparison

BioCardia is currently under evaluation in number of shares shorted category among its peers.

BioCardia Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on BioCardia. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioCardia position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioCardia's important profitability drivers and their relationship over time.

Use BioCardia in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioCardia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCardia will appreciate offsetting losses from the drop in the long position's value.

BioCardia Pair Trading

BioCardia Pair Trading Analysis

The ability to find closely correlated positions to BioCardia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioCardia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioCardia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioCardia to buy it.
The correlation of BioCardia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioCardia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioCardia moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioCardia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your BioCardia position

In addition to having BioCardia in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Electronic Equipment Thematic Idea Now

Electronic Equipment
Electronic Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electronic Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronic Equipment Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Consideration for investing in BioCardia Stock

If you are still planning to invest in BioCardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioCardia's history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA